ToxFinder provides in vitro toxicity models with real predictive power designed to increase competitiveness in an ever changing regulatory environment to support Cosmetic, Toiletry, Bio/Pharmaceutical, Chemical and Nutraceutical industries.
Predictive toxicity
We help our clients to quickly understand the safety profiles of new products allowing them to move about those with the lowest risk for toxicity and hence the highest probability of regulatory and commercial success to market.
- Respiratory toxicity
- skin irritation (TG439)
- skin corrosion (TG431)
- dermal absorption (TG428)
- acute phototoxicity (TG432)
- skin sensitization (proprietary technology)
- immunotoxicity
- cytotoxicity
- mitochondrial toxicity
- endoplasmic reticulum toxicity
Bioscreening
ToxFinder deploys and develops innovative assays in human cell lines which will help our clients to quickly screen the safety profiles and therapeutic potential of new molecules, mainly in the fields of inflammation and oncobiology, based on the research of:
- Anti-inflammatory molecules
- Proinflamatory molecules
- Anticancer molecules
Target Markets/Clients
- Cosmetic Industry
- Pharmaceutical Industry
- Chemical Industry
- Biotech Industry
- Food Industry
- Pesticide Industry
- Nutraceutical Industry